- Relationship provides unique integrated service portfolio for
Pharmaceutical Industry -
MONTREAL, Sept. 8 /CNW/ - Aptilon Corporation (TSX-V: APZ), a leader in
creating online access to physicians for pharmaceutical sales programs, today
announced a strategic partnership with Triple i, a MediMedia company and an
innovative pharmaceutical marketing services provider, to bring enhanced value
to their pharmaceutical clients.
The companies will combine Aptilon's AxcelRx live video detailing service
and ReachNet(SM) Physician Access Channel of more than 450,000 physicians with
Triple i's call center, prescription drug sample fulfillment, alternative
sampling, and medically relevant in-office capabilities. As a result,
physicians will be able to access a broad array of services at their
convenience including drug information, education services with pharmaceutical
company representatives online and, through Triple i's secure online ordering
and fulfillment platform, to order and receive prescription drug samples.
"We continue to build strategic relationships with industry leaders who
deliver added value to our clients and help drive adoption of our AxcelRx
solution," said Roger Korman, Chairman and CEO of Aptilon. "Triple i is a
premier marketing organization for top pharmaceutical companies with its
complete solution for secure online ordering and drug sample fulfillment.
Integrating Aptilon's platform with Triple i's extensive capabilities, allows
us to provide turn-key services for healthcare marketers."
"Our mission includes providing our pharmaceutical marketing clients with
best-in-class marketing and communication services," said Triple i President
Tom Langan. "Partnering with Aptilon and tapping into its ReachNet Physician
Access Channel and its Internet-based AxcelRx live video detailing service
provides synergies that expand our integrated multi-channel non-personal
promotion strategy. Ultimately, we and Aptilon have a shared goal of helping
our clients drive new prescriptions and increase market share at all stages of
the product lifecycle."
Financial terms of the agreement were not disclosed.
About Aptilon Corporation
Aptilon enables pharmaceutical, biotech and medical device companies to
effectively reach and interact with more than 450,000 U.S. physicians via the
Internet through its innovative AxcelRx(SM) live video detailing platform that
delivers promotional, peer selling and sales and marketing programs. Top U.S.
healthcare companies have adopted Aptilon's AxcelRx(SM) Live solution for
their sales representatives to reach leading physicians on-line. Aptilon
provides the infrastructure necessary for companies to build physician
awareness, understanding, and product preference during all stages of a
product's life cycle, from pre-launch education through end-stage support. For
more information, visit www.aptilon.com.
Headquartered in Chatham, NJ, with over 1,600 employees in offices
throughout the U.S. MediMedia's products and services include integrated and
comprehensive health management programs, patient education content, and
applications purchased by healthcare stakeholders: physicians, patients,
employers, hospitals, health plans and pharmaceutical companies. MediMedia's
pharmaceutical marketing group provides solutions for pharmaceutical companies
along their entire marketing continuum, targeting physicians and patients with
superior content and applications. MediMedia's experience in delivering
specialized information to targeted audiences has earned MediMedia
unparalleled trust and respect throughout the industry. For more information,
please visit www.medimedia.com or www.tripleimedimedia.com.
MediMedia is a Vestar Capital Partners portfolio company.
This news release contains forward-looking information. These statements
relate to future events or future performance and reflect management's current
expectations and assumptions. Such forward-looking statements reflect
management's current beliefs and are based on information currently available
to management of Aptilon. A number of factors could cause actual events,
performance or results to differ materially from the events performance and
results discussed in the forward-looking statements. These forward-looking
statements are made as of the date hereof and Aptilon does not assume any
obligation to update or revise them to reflect new events or circumstances.
For further information:
For further information: For U.S. Media: Mark Gleason, Aptilon
Corporation, (847) 331-8628, email@example.com; Jed Weiner, White Oak
Communications, Inc., (847) 910-1330, firstname.lastname@example.org; Russ Sieger,
Triple i, (267) 685-2396, email@example.com; For Canadian Media: Wendy
Hernandez, Aptilon Corporation, (514) 844-8866, firstname.lastname@example.org